{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:50:51Z","timestamp":1787028651900,"version":"build-2736575974"},"reference-count":40,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Philips Healthcare"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Type 2 diabetes mellitus (T2DM) represents a major risk factor for peripheral artery disease (PAD). We aimed to evaluate the impact of T2DM on lesion localization and complexity, clinical presentation by Rutherford categories, and limb outcomes in elderly patients with symptomatic PAD undergoing endovascular revascularization. Methods: Five hundred consecutive patients with symptomatic infra-inguinal PAD who underwent rotational atherectomy-assisted endovascular revascularization were included. PAD clinical presentation and lesion localization were recorded. The primary endpoints were clinically driven target lesion revascularization (CD-TLR) and major amputation rates during follow-up. Results: Overall, 245\/500 (49.0%) patients had T2DM, whereas 179 (35.8%) presented with lifestyle limiting claudication and 321 (64.2%) with critical limb-threatening ischemia (CLTI). Median age was 78.0 (IQR = 70.0\u201384.0) years, and 201 (40.2%) patients were female. The presence of T2DM was significantly more frequent in patients with CLTI vs. those with claudication (58.6 vs. 31.8%; p &lt; 0.001). Furthermore, the percentage of patients with below-the-knee (BTK) lesions was significantly higher in patients with vs. without T2DM (40.7 vs. 27.5%, p = 0.0002). During median follow-up of 21.9 (IQR = 12.8\u201328.8) months, CD-TLR rates were similar in patients with vs. without T2DM (HR = 1.2, 95%CI = 0.8\u20132.0, p = 0.39). However, patients with T2DM had a ~5.5-fold increased risk for major above-the-ankle amputation (HR = 5.5, 95%CI = 1.6\u201319.0, p = 0.007). After adjustment for age, gender, lesion complexity, and calcification, T2DM remained predictive for major amputation (p = 0.04). Conclusions: T2DM is more frequently associated with CLTI, BTK-PAD, and amputations despite successful endovascular revascularization. More stringent surveillance of patients with PAD and T2DM is warranted to prevent atherosclerosis-related complications.<\/jats:p>","DOI":"10.3390\/jcm13216385","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T08:42:13Z","timestamp":1729845733000},"page":"6385","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lesion Localization and Limb Outcomes in Elderly Patients with and Without Type 2 Diabetes Mellitus Who Undergo Atherectomy-Assisted Endovascular Revascularization due to Symptomatic Peripheral Artery Disease"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0894-2644","authenticated-orcid":false,"given":"Niki","family":"Katsiki","sequence":"first","affiliation":[{"name":"Department of Nutritional Sciences and Dietetics, International Hellenic University, 57400 Thessaloniki, Greece"},{"name":"School of Medicine, European University Cyprus, Nicosia 2404, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Geiss","sequence":"additional","affiliation":[{"name":"Cardiology and Vascular Medicine, GRN Hospital Weinheim, 69469 Weinheim, Germany"},{"name":"Weinheim Cardiovascular Imaging Center, Hector Foundation, 69469 Weinheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Giesen","sequence":"additional","affiliation":[{"name":"Cardiology and Vascular Medicine, GRN Hospital Weinheim, 69469 Weinheim, Germany"},{"name":"Weinheim Cardiovascular Imaging Center, Hector Foundation, 69469 Weinheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amila","family":"Jehn","sequence":"additional","affiliation":[{"name":"Cardiology and Vascular Medicine, GRN Hospital Weinheim, 69469 Weinheim, Germany"},{"name":"Weinheim Cardiovascular Imaging Center, Hector Foundation, 69469 Weinheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Rammos","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University of Duisburg-Essen, 45122 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.","family":"Karcher","sequence":"additional","affiliation":[{"name":"Cardiology and Vascular Medicine, GRN Hospital Weinheim, 69469 Weinheim, Germany"},{"name":"Weinheim Cardiovascular Imaging Center, Hector Foundation, 69469 Weinheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Sch\u00f6fthaler","sequence":"additional","affiliation":[{"name":"Cardiology and Vascular Medicine, GRN Hospital Weinheim, 69469 Weinheim, Germany"},{"name":"Weinheim Cardiovascular Imaging Center, Hector Foundation, 69469 Weinheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6038-2253","authenticated-orcid":false,"given":"Grigorios","family":"Korosoglou","sequence":"additional","affiliation":[{"name":"Cardiology and Vascular Medicine, GRN Hospital Weinheim, 69469 Weinheim, Germany"},{"name":"Weinheim Cardiovascular Imaging Center, Hector Foundation, 69469 Weinheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s13300-024-01606-6","article-title":"Epidemiology and Burden of Peripheral Artery Disease in People with Type 2 Diabetes: A Systematic Literature Review","volume":"15","author":"Verma","year":"2024","journal-title":"Diabetes Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"100113","DOI":"10.1016\/j.lanepe.2021.100113","article-title":"Peripheral artery disease in Germany (2009\u20132018): Prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy\u2014A population-based study","volume":"5","author":"Rammos","year":"2021","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4239\/wjd.v12.i6.827","article-title":"Diabetes and peripheral artery disease: A review","volume":"12","author":"Soyoye","year":"2021","journal-title":"World J. Diabetes"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e002407","DOI":"10.1136\/bmjdrc-2021-002407","article-title":"Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease","volume":"9","author":"Sprenger","year":"2021","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Singh, M.V., and Dokun, A.O. (2023). Diabetes mellitus in peripheral artery disease: Beyond a risk factor. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1148040"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.coph.2018.01.003","article-title":"Lipid-lowering treatment in peripheral artery disease","volume":"39","author":"Katsiki","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1080\/14656566.2017.1351946","article-title":"Cardiovascular disease prevention strategies for type 2 diabetes mellitus","volume":"18","author":"Katsiki","year":"2017","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Donas, K.P., Psyllas, A., Pitoulias, A.G., Kazemtash, M., Dahi, F., Abu Bakr, N., and Korosoglou, G. (2023). Periprocedural Outcomes of Rotational Atherectomy-Assisted Balloon Angioplasty in Isolated Atherosclerotic Popliteal Artery Lesions: The ISO-POP Trial. J. Clin. Med., 12.","DOI":"10.3390\/jcm12082797"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e432","DOI":"10.4244\/EIJ-D-21-01070","article-title":"Phoenix atherectomy for patients with peripheral artery disease","volume":"18","author":"Giusca","year":"2022","journal-title":"EuroIntervention"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jcin.2021.09.034","article-title":"Retrograde Access for the Recanalization of Lower-Limb Occlusive Lesions: A German Experience Report in 1,516 Consecutive Patients","volume":"15","author":"Korosoglou","year":"2022","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ejvs.2023.12.037","article-title":"Retrospective Case Control Matched Comparison of the Antegrade versus Retrograde Strategy after Antegrade Recanalisation Failure in Complex de novo Femoropopliteal Occlusive Lesions","volume":"67","author":"Trenkler","year":"2024","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_13","first-page":"205","article-title":"Atherectomy plus antirestenotic therapy for SFA lesions: Evolving evidence for better patency rates in complex lesions","volume":"60","author":"Lichtenberg","year":"2019","journal-title":"J. Cardiovasc. Surg. (Torino)"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race","volume":"385","author":"Inker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jcin.2022.11.036","article-title":"Crossing Algorithm for Infrainguinal Chronic Total Occlusions: An Interdisciplinary Expert Opinion Statement","volume":"16","author":"Korosoglou","year":"2023","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Korosoglou, G., Feld, J., Langhoff, R., Lichtenberg, M., Stausberg, J., Hoffmann, U., Rammos, C., Malyar, N., and Investigators, R. (2024). Safety and Effectiveness of Debulking for the Treatment of Infrainguinal Peripheral Artery Disease. Data From the Recording Courses of vascular Diseases Registry in 2910 Patients. Angiology, 33197241263381.","DOI":"10.1177\/00033197241263381"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1177\/00033197221075857","article-title":"Safety and Effectiveness of Endovascular Therapy for the Treatment of Peripheral Artery Disease in Patients with and without Diabetes Mellitus","volume":"73","author":"Korosoglou","year":"2022","journal-title":"Angiology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s00270-014-0904-3","article-title":"Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease","volume":"37","author":"Fanelli","year":"2014","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/1358863X15597877","article-title":"An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"20","author":"Committee","year":"2015","journal-title":"Vasc. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"155332","DOI":"10.1016\/j.metabol.2022.155332","article-title":"Pharmacotherapy of type 2 diabetes: An update and future directions","volume":"137","author":"DeMarsilis","year":"2022","journal-title":"Metabolism"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2215\/CJN.07891109","article-title":"Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes","volume":"5","author":"Plantinga","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","article-title":"Non-alcoholic fatty liver disease and dyslipidemia: An update","volume":"65","author":"Katsiki","year":"2016","journal-title":"Metabolism"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"155664","DOI":"10.1016\/j.metabol.2023.155664","article-title":"From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): An ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need","volume":"147","author":"Kokkorakis","year":"2023","journal-title":"Metabolism"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1124\/pharmrev.123.001087","article-title":"Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies","volume":"76","author":"Kokkorakis","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5114\/aoms\/183070","article-title":"The Cardiac-Kidney-Liver (CKL) syndrome: The \u201creal entity\u201d of type 2 diabetes mellitus","volume":"20","author":"Katsiki","year":"2024","journal-title":"Arch. Med. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"154218","DOI":"10.1016\/j.metabol.2020.154218","article-title":"New American Diabetes Association (ADA)\/European Association for the Study of Diabetes (EASD) guidelines for the pharmacotherapy of type 2 diabetes: Placing them into a practicing physician\u2019s perspective","volume":"107","author":"Katsiki","year":"2020","journal-title":"Metabolism"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.5114\/aoms.2019.89449","article-title":"Is type 2 diabetes mellitus a coronary heart disease equivalent or not? Do not just enjoy the debate and forget the patient!","volume":"15","author":"Katsiki","year":"2019","journal-title":"Arch. Med. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ejhf.1359","article-title":"The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes","volume":"21","author":"Rorth","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ihj.2015.09.026","article-title":"Comparative analysis of biochemical parameters in diabetic and non-diabetic acute myocardial infarction patients","volume":"68","author":"Ali","year":"2016","journal-title":"Indian. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Cimaglia, P., Dalla Paola, L., Carone, A., Scavone, G., Manfrini, M., Brogneri, S., Tenti, E., Pavasini, R., Bernucci, D., and Passarini, G. (2021). High-Sensitivity Cardiac Troponin Predicts Major Cardiovascular Events in Diabetic Patients with Critical Limb Ischemia and Foot Lesions. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.595701"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/clc.23776","article-title":"Cardiac troponins predict mortality and cardiovascular outcomes in patients with peripheral artery disease: A systematic review and meta-analysis of adjusted observational studies","volume":"45","author":"Vrsalovic","year":"2022","journal-title":"Clin. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Mouselimis, D., Hagstotz, S., Lichtenberg, M., Donas, K.P., Heinrich, U., Avranas, K., Dimitriadis, Z., Blessing, E., Langhoff, R., and Frey, N. (2022). Cardiac Troponins for the Clinical Management of Patients with Claudication and without Cardiac Symptoms. J. Clin. Med., 11.","DOI":"10.3390\/jcm11247287"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1161\/CIRCULATIONAHA.115.016424","article-title":"Population-Based Study of Incidence, Risk Factors, Outcome, and Prognosis of Ischemic Peripheral Arterial Events: Implications for Prevention","volume":"132","author":"Howard","year":"2015","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.2337\/dc16-0850","article-title":"Diabetes Is Associated with Decreased Limb Survival in Patients with Critical Limb Ischemia: Pooled Data From Two Randomized Controlled Trials","volume":"39","author":"Spreen","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/01.CIR.0000089189.70578.E2","article-title":"Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part II","volume":"108","author":"Luscher","year":"2003","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12933-021-01441-0","article-title":"Diabetes and other vascular risk factors in association with the risk of lower extremity amputation in chronic limb-threatening ischemia: A prospective cohort study","volume":"21","author":"Ying","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/ATVBAHA.120.314595","article-title":"Epidemiology and Risk of Amputation in Patients with Diabetes Mellitus and Peripheral Artery Disease","volume":"40","author":"Barnes","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCULATIONAHA.123.067687","article-title":"Illness Trajectories after Revascularization in Patients with Peripheral Artery Disease: A Unified Approach to Understanding the Risk of Major Amputation and Death","volume":"150","author":"Li","year":"2024","journal-title":"Circulation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.jvs.2016.07.107","article-title":"Diabetes does not worsen outcomes following infrageniculate bypass or endovascular intervention for patients with critical limb ischemia","volume":"64","author":"Hicks","year":"2016","journal-title":"J. Vasc. Surg."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2024). 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024. Diabetes Care, 47, S158\u2013S178.","DOI":"10.2337\/dc24-S009"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/21\/6385\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:20:04Z","timestamp":1760113204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/21\/6385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":40,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["jcm13216385"],"URL":"https:\/\/doi.org\/10.3390\/jcm13216385","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]}}}